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Abstract
Background: The most common cause of idiopathic nephrotic syndrome in children and younger
adults is the minimal change nephrotic syndrome (MCNS). In the elderly MCNS is relatively
uncommon. Over the last decade some reports suggest a rare but possible association with the
administration of various vaccines.
Case presentation: A 82-year old Caucasian female presented with pronounced nephrotic
syndrome (proteinuria of 7.1 g/d, hypoproteinemia of 47 g/l). About six weeks prior to admission,
she had received a combination vaccination for tetanus, diphtheria and poliomyelitis as a booster-
vaccination from her general practitioner. The renal biopsy revealed typical minimal change lesions.
She responded well to the initiated steroid treatment. As through physical examination as well as
extensive laboratory and imaging studies did neither find any evidence for malignancies nor
infections we suggest that the minimal change nephrotic syndrome in this patient might be related
to the activation of the immune system triggered by the vaccination.
Conclusion: Our case as well as previous anecdotal reports suggests that vaccination and the
resulting stimulations of the immune system might cause MCNS and other severe immune-
reactions. Increased awareness in that regard might help to expand the database of those cases.
Background
The most common cause of idiopathic nephrotic syn-
drome in children and younger adults is the minimal
change nephrotic syndrome (MCNS). In the elderly
MCNS is relatively uncommon. If present it can be associ-
ated with several conditions as malignancies [1], viral
infections, allergies [2] and various drugs. Over the last
ten years four anecdotal reports linking MCNS to vaccina-
tions against hepatitis [3-5] pneumococcus [6] and influ-
enca [7] have been published. Here we report the first case
of MCNS following a combined tetanus-diphteria-polio-
myelitis-vaccination and also summarize all previous
published reports on MCNS after vaccination.
Case presentation
An 82 year old Caucasian female was admitted to our hos-
pital in April 2008 with pitting edema of her legs arms and
back. Her past medical history was significant for an
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appendectomy at the age of 29 years, a hyster- and ova-
riectomy at the age of 50 years, as well as status post vari-
cose stripping, bilateral knee arthrosis,
hypercholesterolemia and a reported diphtheria infection
as a child. No history of allergic diseases or malignoma
was present. Her regular medication consisted of low dose
acetylsalicylic acid (100 mg/d), simvastatine (5 mg/d)
and occasionally diclofenac (about 3 times a year, last
time four months prior to admission). The outpatient
nephrologist started medical therapy with spironolactone
(25 mg) and furosemide (up to 400 mg/d) three days
prior to admission. Laboratory data from her routine out-
patient visits showed no proteinuria as well as normal
renal function until January 2007.
On January 17th 2008, the patient received a combined
intramuscular vaccination for tetanus, diphtheria and
poliomyelitis (REVAXIS, Sanofi Pasteur MSD GmbH, Lei-
men, Germany), as her last vaccination for tetanus had
been performed in April 1998. The vaccination was com-
posed of cleaned tetanus toxoid, cleaned diphtheria tox-
oid, inactive poliomyelitis virus Typ 1–3,
aluminiumhydroxide, 2-Phenoxyethanol, formaldehyde,
medium 199 (mixture of aminoacids, minerals, vitamins,
polysorbat 80) and trace amounts of neomycin, strepto-
mycin and polymyxin B. No local vaccination reaction
occurred after injection. At the end of February slight leg
edema occurred. The general practitioner performed
echocardiography for suspected heart failure. As the
echocardiography revealed only mild aortic-valve-insuffi-
ciency and mild mitral valve-insufficiancy, with an intact
overall contractility this diagnosis was dismissed. Mean-
while the edema worsened constantly, impressively indi-
cated by an increase in bodyweight from 72 kg to 84 kg in
one month. Moreover, the previous normotensive patient
became hypertensive with blood pressure of 186/101
mmHg. Urinary dip-stick analysis now showed massive
(+++) proteinuria on which the patient was transferred to
a nephrologist. The 24 hours collected urine showed mas-
sive unselective proteinuria (12 g/day), therapy with
spironolactone and furosemide failed to alleviate the ede-
matous state. The urine sediment revealed multiple eryth-
rocyte cylinders on which the patient was transferred to
our tertiary care hospital for further nephrological evalua-
tion and treatment. Upon admission physical examina-
tion was significant for general edema and multiple
localised makulopapulous exanthema of the feet and legs.
Vital parameters were unremarkable. The chest radio-
graph showed no signs of pleural effusions or malignan-
cies. Laboratory tests revealed unselective nephrotic
proteinuria (7.13 g/d), hypoproteinemia (47 g/l) and
hypercholesterolemia (605 mg/dl). Serum creatinine was
74 μmol/l. The 24 hour collected urine revealed a reduced
creatinine-clearance of 46 ml/min. Urinary sediment
showed mild microhaematuria (5–10 erythrocytes/μl)
and a few granulated and hyaline cylinders but no signs of
an active sediment. Analysis for antinuclear antibodies,
ANCA, antibodies against double-strain-DNS, anti-GBM-
antibodies and Hepatitis B and C were negative or within
normal limits. The kidneys were of normal size but
showed bilateral mild enhancement in the abdominal
ultrasound. Further diagnostic workup showed no evi-
dence of malignancies.
Renal biopsy was performed and showed typical minimal
change lesion without evidence of focal and segmental
glomerulosclerosis (Figure 1). Three of the 22 glomerula
showed globalsclerosis, minimal tubulo-atrophie and
interstitial fibrosis (< 5% of the cortex). Further immuno-
logical staining excluded mesangial and glomerular IgM,
IgA, IgG, C3 or fibrin/fibrinogen deposits.
After minimal change diagnosis was assured by biopsy,
therapy with steroids (1 mg/kg body weight/day) and an
ACE-inhibitor (ramipril 5 mg/d) was initiated. After ten
days of therapy with steroids (75 mg/d) with concomitant
oral phenprocourmon the nephrotic range proteinuria
reduced to 1.17 g/24 h (Figure 2). On the last follow-up
in the end of April 2009 serum-creatinine fell to 62 μmol/
l, the blood pressure normalized and proteinuria was not
detectable in a 24 h urine collection.
Methods
For this paper we searched PubMed for relevant articles
using the following medical subject headings: "minimal
Light-microscopy of a representative Glomerulum and the  tubulus-interstitium (A, B) and ultrastructure of a glomeru- lum with missing podocytes and thin basements without  deposits (C, D) Figure 1
Light-microscopy of a representative Glomerulum 
and the tubulus-interstitium (A, B) and ultrastruc-
ture of a glomerulum with missing podocytes and 
thin basements without deposits (C, D).BMC Nephrology 2009, 10:21 http://www.biomedcentral.com/1471-2369/10/21
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change nephropathy," "vaccination," through Feburary 1,
2009. We supplemented the search by scanning references
of selected articles identified by this search.
Conclusion
Minimal change nephrotic syndrome (MCNS) is a major
cause of nephrotic syndrome in both children and
younger adults. Although the exact underlying cause of
MCNS is not fully understood a burgeoning body of evi-
dence suggests that systemic T cell dysfunction results in
the production of a glomerular permeability factor. This
circulating factor directly induces foot process fusion
resulting in severe alteration of the glomerular filter sys-
tem and resulting in marked proteinuria. The clinical and
histopathological findings in our patient as well as the
course of the disease were typical for MCNS. This syn-
drome is rarely seen in elderly patients (3/million/year)
[8]. The fact that our patient did not exhibit any other con-
dition known to be associated with MCNS at the time of
presentation nor on follow up, suggests that the vaccina-
tion might have caused MCNS in our patient.
To date six reports of MCNS after vaccination had been
published, including our report (Table 1). The first pub-
lished evidence for a nephrotic syndrome following vacci-
nation is given in an article from Chamberlain et. al in
1966 [9]. A woman suffered a nephrotic syndrome 10
days after smallpox vaccination. Biopsy and later necropsy
was performed showing slight basement thickening mak-
ing MCGN an unlikely diagnosis. In all presented cases
the patients suffered a nephrotic syndrome shortly after
vaccination of different sera (Tetanus-diphteria-poliomy-
elitis; Pneumococcus; Influenza; Hepatitis B). In 4 cases
diagnosis was assured by biopsy, except one patient all
others were treated with steroids. In three of the published
cases follow-up phase was negative concerning proteinu-
ria. Our patient reported the occasional use of diclofenac.
Non-steroidal-anti-rheumatic-drugs (NSAID's) are well
known to cause MCGN as Galesic et al have recently pub-
Clinical course of the patient Figure 2
Clinical course of the patient.
Table 1: Summary of MCNS following vaccination in literature
Vaccination against Tetanus-diphteria-
poliomyelitis-
vaccination
Pneumococcus [6] Influenza [7] Hepatitis B [3] Hepatitis B [4] Hepatitis B [5]
Age [years] 82 67 65 3 40 4
Gender female female female male female male
Baseline creatinine 76 μmol/l no data normal 44 μmol/l normal no data
Peak creatinine 138 μmol/l 274 μmol/l 158 μmol/l no data no data no data
Baseline 
proteinuria
negative in dip-
stick
past history 
unremarkable
no data past history 
unremarkable
past history 
unremarkable
past history 
unremarkable
Peak proteinuria 12 g/day 10.4 g/day 13.2 g/day 24.8 g/day 8 g/day 1.25 g/day
Vaccination to 
onset of 
symptoms
4 weeks 4 months 4 days 17 days after 2nd 
inoculation
8 days
Biopsy typical minimal 
change lesion 
(MCL)
MCL and mild 
interstitial 
nephritis
typical minimal 
change lesion 
(MCL)
not indicated minimal change 
nephropathy
not indicated
Treatment Steroids 1 mg/kg 
bw ACE-inhibitor
750 mg Steroids 
for 3 days; 
followed by 40 mg/
day
None specific Steroids 2 mg/kg 
bw
Steroids 
(12 mg every 
other day)
Steroids 2 mg/kg 
bw
Renal function/
follow up
80 μmol/l
6 months after 
diagnosis
Urinary protein 
neg. after one 
year; 15 mg 
Steroids/day
Clearacnce 95 ml/
min after one year
no data no data Complete 
remissionBMC Nephrology 2009, 10:21 http://www.biomedcentral.com/1471-2369/10/21
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lished [10]. In our case this cause is unlikely because the
patient denied the use of any NSAID four month prior to
the admission.
On admission in our hospital the patient complained of
multiples makulopapulous exanthema on her legs which
shortly occurred after the ambulatory start of the diuretic
therapy with furosemide. As furosemide is known to cause
skin exanthema [11] and the lesions disappeared after dis-
continuation of the loop-diuretic, we attribute the skin
lesions to the furosemide administration as an allergic
drug exanthema and not as an erythema exsudativum
multiforme as a sign for an infection. The allergic origin is
supported by the fact that was a lag period between the
clinical signs of the nephritic syndrome and a temporal
association between the begin of the furosemid therapy
and the begin of the exanthema.
In our patient the time of onset of the nephrotic syndrome
after the vaccination correlates with the reported time at
which seroprotective antibody-levels are confirmed after
vaccination with REVAXIS (28 days after injection)
[12,13]. The time until the onset of symptoms varies in all
described cases cases from days to months, which could
be explained by the different time it took for the respective
vaccine to trigger an immune response. Nephrotic syn-
drome occurred after the second administration of the
vaccine which suggests that the last administration has
boosted a pre-existing immune response from the first
vaccination. Similar findings are described in a case from
Floege et al. [19].
Another serious reaction after vaccination on renal func-
tion is described in several cases. Santoro reported a Lupus
nephritis as an uncommon complication following a hep-
atitis B vaccination [14]. In another case from Poland, a
17-year-old girl suffered a necrotizing glomerulonephritis
after a vaccination against influenza, which underlines the
hypothesis of the activation of the immune-system after
vaccination [15].
Should we than stop vaccinations, at least for children
with nephrotic syndrome? In a study assessing the relapse
rate of 54 children with known steroidsensitive nephrotic
syndrome showed no evidence that meningococcal C con-
jugate vaccine (MCCV) triggered relapses of nephrotic
syndrome [16]. This is in contrast to findings by Abeya-
gunawardena and colleagues who advised to carefully
consider the vaccination of children with steroid-sensitive
nephrotic syndrome. In their cohort of 106 children with
nephrotic syndrome showed a significantly higher relapse
rate after MCCV-vaccination with a relative incidence of
1.52 (95% CI 1·10–2·11) comparing 12 months pre-
and post-vaccination [17]. This is in line with a another
study showing a nephrotic syndrome relapse rate of 9%
after vaccination against viral hepatitis B in children [18].
In summary, various vaccinations are associated with a
higher relapse of steroid-sensitive nephrotic syndrome,
yet the benefit for the preventive medicine prevails the
risks of triggering a relapse these patients. The currently
available data do in our view not allow giving any firm
recommendation concerning the use vaccines patients
with nephrotic syndrome. In the general population the
benefit of various vaccines has been clearly documented
as an effective way of primary prevention of diseases.
Extremely rare side effects of vaccinations, like MCNS, can
by no means outweigh the benefits of vaccinations.
It is beyond the scope of a case report to elucidate the pos-
sible pathophysiology between the immune response
after vaccination in MCNS. Still one could hypothesize
that under certain preconditions, the immune response
after vaccination influences the cytosceleton of podocytes,
leading to proteinuria. Indeed, recent publications
showed that the podocyte is not only heavily equipped
with cytokine receptors but is also a target of immunosup-
pressive drugs like cyclosporin. Hence, podocyte integrity
could, under certain preconditions, be altered in the con-
text of a stimulated immune system after vaccination.
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